Dr Jacques Medioni and Dr Jean-Pierre Bizzari join company’s scientific board – bringing their extensive oncology expertise to help Seekyo enter clinic with SKY01 drug candidate targeting solid tumorsPoitiers, France, January 17, 2022 – Seekyo, a startup company specializing in developing smart chemotherapy drugs, t.
CoVepiT demonstrated generation of sentinel memory T cells with
long-term protective effect against COVID-19 in preclinical and human ex vivo studies
CoVepiT targets 11 virus proteins to prepare for potential mutations
Clinical trial expected to start in Q1 2021
OSE Immunotherapeutics committed to grant the French government a purchase option on doses of CoVepiT vaccine
NANTES, France, Dec. 18, 2020 (GLOBE NEWSWIRE)
OSE Immunotherapeutics (ISIN: FR0012127173; Mnemo: OSE) announces that the Company has obtained funding of €5.2 million under the PSPC-COVID call for projects, operated on behalf of the French government by Bpifrance as part of the
Programme d’investissements d’avenir (PIA) and led by the
OSE Immunotherapeutics Receives €5 2 M in Public Funding for the Clinical Development of CoVepiT, its Second Generation COVID-19 Vaccine wboc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wboc.com Daily Mail and Mail on Sunday newspapers.